| 12/09/2011 |
Foamix to Present at the UBS 2011 Global Life Sciences Conference, Including an Update on its First-in-Class Topical Minocycline Foam , Now in Phase II for Acne, Rosacea and Skin Infections
|
| 01/09/2011 |
Foamix Receives Approval for Minocycline Foam Phase II Clinical Trial in Acne
|
| 27/07/2011 |
Survey reveals: 77% of Dermatologists will Prescribe Topical Minocycline. Foamix’s first-in-class Minocycline Foam - now in phase II
|
| 18/01/2011 |
Foamix Announces Phase II Clinical Trial of Topical Minocycline Foam for Rosacea
|
| 04/11/2010 |
Foamix Receives US Patent for Oleaginous Foam
|
| 01/11/2010 |
Foamix and BioMAS to Develop Novel Therapy for Genital Warts
|
| 31/05/2010 |
Foamix to present at the UBS 2010 Global Specialty Pharmaceuticals Conference
|
| 20/05/2010 |
New U.S. Patent Grant to Foamix for its Hygroscopic and Waterless Breakable Foam Technology
|
| 29/04/2010 |
Foamix Receives a New U.S. Patent for its Emollient and Aqueous Foam Technology
|
| 26/04/2010 |
Foamix is Granted a Fourth U.S. Patent for OilGel™,
Directed to Pharmaceutical Compositions and their Dermatological, Gynecological and Ophthalmic Applications
|
| 03/03/2010 |
Foamix Ltd. and Therapeutics
Inc. Enter into Joint Venture to Develop New Prescription Foams for Inflammatory Skin Diseases
|
| 04/01/2010 |
US Grant for Foamix's Saccharide Foam Patent Adds Depth to Foamix's Broad Intellectual Portfolio and Protects Topical "Sweet Foam" Products for Wound & Burn Therapy
|
| 04/01/2010 |
Foamix is a Finalist for the Red Herring 100 Global Award for Most Promising Technology Ventures |
| 04/11/2009 |
Foamix Expands International Patent Protection for its Emollient Foam Platform |
| 03/11/2009 |
Foamix Extends Collaboration with Galderma |
| 02/02/2009 |
Foamix Ltd. and VIB Sign Co-Development Agreement for Innovative Topical Therapy for Psoriasis |
| 28/01/2009 |
Promius Pharma, LLC Launches Scytera™ (Coal Tar) Foam 2% for Treatment of Psoriasis |
| 08/12/2008 |
Foamix is Finalist for International 2008 SCRIP Award |
| 03/06/2008 |
Ferndale and Foamix Execute License Agreement for Development of Non-Steroidal Foam for Atopic Dermatitis |
| 13/05/2008 |
Omnibus Survey: 72% of Women Are Dissatisfied with Their Current Treatment of Vaginal Infection |
| 29/04/2008 |
Foamix and Galderma to Develop Medicated Foam for Certain Skin Diseases |
| 26/03/2008 |
Foamix is a
Finalist for the Red Herring 100 Europe 2008 Award |
| 13/11/2007 |
Foamix Announces New Foam Patent Approvals
|
| 05/11/2007 |
Ferndale and Foamix Enter Development of an Innovative Foam for the Treatment of Atopic Dermatitis
|
| 29/10/2007 |
Foamix Acquires Rights to Dual Chamber Aerosol Foam Technology
|
| 09/07/2007 |
Foamix Presents Innovative Intra-Vaginal Foam Delivery for Gynecology
|
| 24/01/2007 |
Foamix Signs R&D Collaboration and License Agreement with Dr. Reddy’s for the Development and Commercialization of Psoriasis Foam
|
| 20/01/2007 |
Warner Chilcott and Foamix Collaborate on Gynecologic Foam Product
|
| 10/01/2007 |
Foamix and Intendis Sign License Agreement for the Development of a Dermatological Foam
|
| 03/01/2007 |
Warner Chilcott and Foamix Collaborate on
Foam Product for the Treatment of Acne
|
| 24/07/2006 |
Foamix Announces New Waterless Foam Designed for Enhanced Skin Delivery - Useful for Steroids and Water Sensitive Drugs |
| 20/07/2006 |
Foamix’s Betamethasone Foam Demonstrates High Efficacy in Psoriasis Treatment and 85% Better Usability than Cream in Phase I/II Study |
| 17/07/2006 |
Foamix Names David Schuz as Senior Vice President, Intellectual Property. |
| 29/03/2006 |
Foamix CEO to Present “The Changing Face of Dermatology”
at the Bio Business Forum at Bio International 2006 in Chicago, April 10, 2006 |
07/02/2006
|
Foamix Receives Patents for OilGel™ In the U.S. and in Australia
|
28/11/2005
|
Foamix Granted Third U.S. Patent for OilGel™, In Development for Dermatological and Ophthalmic Applications
|
03/11/2005
|
Foamix Executive Director Dr. Stanley Hirsch
to Present
“Foamix - Innovative Delivery in Dermatology”
at Bio-Europe 2005, November 8th at 8:30 a.m.
|
12/09/2005
|
Foamix Commences Phase II Study of
TerbiFoam™ 2% Foam for the Treatment of Athlete’s Foot. Company Concurrently Conducts Phase II Study of Betamethasone 0.12% Emollient Foam for the Treatment of Psoriasis
|
12/09/2005
|
Foamix to Showcase Emulsion-Based Cosmetic Foams at
The Health and Beauty America (HBA) Conference in New York
|
18/07/2005
|
Foamix’s PerFoam™ for the Treatment of Lice Demonstrates Safety and 96% Efficacy in Phase II/III Study
|
08/06/2005
|
Foamix Selected to Present at the Bio Business Forum
at Bio International 2005 in Philadelphia in June
|
06/02/2005
|
Foamix "Breaks the Ribbon" on New Facility |
04/02/2005
|
Foamix Unveils Unique Mupirocin Foam |
02/06/2004
|
Foamix Unveils Innovative Vaginal Foam |
| 15/09/2003 |
Phase II Psoriasis Study Approved |
| 10/06/2003 |
Foamix Unveils Revolutionary Dermatological Foams |
| |
|
